Description of the Business Sample Clauses

Description of the Business. The Company is a clinical stage pharmaceutical company focused on the development and commercialization of radiotherapeutics and theranostic products. The company will compete in all medical therapeutic categories.
AutoNDA by SimpleDocs
Description of the Business. The Resident may conduct only the business described below.
Description of the Business. The Company is a clinical stage pharmaceutical company focused on the development and commercialization of radiotherapeutics and theranostic products. The company will compete in therapeutic categories related to the use of radiotherapeutics and theranostic products in oncology. Exhibit 2.1: Description of Duties – Executive Vice President, Clinical Development The Executive Vice President, Clinical Development reports directly to the CEO and leads all clinical development activities, including Managing Biostatistics & Programing, Data Management, Clinical Imaging, Clinical Operations, & Clinical Science to support clinical development activities in US and Canada, and may include jurisdictions in Europe and the rest of the world. In this role you will make strategic decisions to achieve the Company’s stated development, business and financial objectives. ESSENTIAL DUTIES AND RESPONSIBILITIES · Design, oversee and execute on clinical and regulatory strategy · Serve as the clinical lead in FDA meetings and Regulatory document preparation including Information Packages, Clinical Study Reports and clinical NDA content (e.g. ISS, SCS, ISE, SCE, SAP) · Oversee clinical research resourcing including consultants, CROs and other vendors to ensure optimization and effectiveness of clinical program deliverables within allocated budgets · Lead Investigator Meetings, Steering Committee and Advisory Board meetings to gain strategic input into study design, data analysis and patient/physician needs · Set and manage the annual clinical budget · Set the clinical development road map and associated budgets · Lead KOL engagement to incorporate current concepts and direction within clinical programs · Support commercialization and launch activities of product candidates · With the leadership team, create and deploy the Company’s vision and mission and short- and long-term objective and strategies · Develop high quality business strategies and plans ensuring their alignment with short-term and long-term objectives · Work with the leadership team to develop the corporate objectives to achieve the Company’s goals · Create an environment that promotes great performance and positive morale Maintain an awareness of the competitive market landscape, expansion opportunities and industry developments · Ensure that the Company maintains high social responsibility and ethics wherever it does business · Assess risks to the Company and ensures they are monitored and minimized Build allian...
Description of the Business. Xtribe is a free application which geolocates products and services offered by private individuals and businesses in the vicinity of the user. Part II
Description of the Business. The Business sold hereby comprises all of the assets set forth herein below: XXXX ET ASSOCIES FINAL APRIL 24, 2003
Description of the Business. The Company is a development-stage pharmaceutical company focused on a proprietary compound named EPI-506 as a treatment for advanced prostate cancer. EPI-506 was designed to block a novel target on the androgen receptor, the N-terminal domain. It is widely accepted that blocking the N-terminal domain of the androgen receptor has the potential to block tumor growth after current hormone-therapy drugs have failed.
Description of the Business. With the exclusion of the items set out in section 2.2.3, the Business consists in the development, manufacture and distribution of the Products, as described in Schedule 2.2, for haematology laboratories and blood banks and comprises the following assets:
AutoNDA by SimpleDocs
Description of the Business. The Company is a development-stage pharmaceutical company focused on the development of oncology therapies or diagnostics based on targeting the N terminal domains of receptors including but not limited to the proprietary compounds named EPI-002 and EPI-506 as a treatment for advanced prostate cancer. In addition, the Company is engaged in the business of developing novel therapeutics for cancer, and therefore compounds or classes of compounds that are actively being developed by the Company will be identified and included in the description of the Business, which may be amended by the Company from time to time.
Description of the Business 

Related to Description of the Business

  • Operation of the Business Between the date of this Agreement and the Closing, Seller shall:

  • Condition of the Business (a) Notwithstanding anything contained in this Agreement to the contrary, Purchaser acknowledges and agrees that Seller is not making any representations or warranties whatsoever, express or implied, beyond those expressly given by Seller in Article V hereof (as modified by the Seller Schedules as supplemented or amended), and Purchaser acknowledges and agrees that, except for the representations and warranties contained therein, the Purchased Assets and the Business are being transferred on a “where is” and, as to condition, “as is” basis. Any claims Purchaser may have for breach of representation or warranty shall be based solely on the representations and warranties of Seller set forth in Article V hereof (as modified by the Seller Schedules as supplemented or amended). Purchaser further represents that neither Seller nor any of its Affiliates nor any other Person has made any representation or warranty, express or implied, regarding Seller, the Purchased Assets, the Business or the transactions contemplated by this Agreement or as to the accuracy or completeness of any information not expressly set forth in this Agreement and neither Purchaser nor any of its Affiliates has relied on any such express or implied representation or warranty. Purchaser further agrees that none of Seller, any of its Affiliates or any other Person will have or be subject to any liability to Purchaser or any other Person resulting from the distribution to Purchaser or its representatives or Purchaser’s use of, any such information, including any confidential memoranda distributed on behalf of Seller relating to the Business or other publications or data room information provided to Purchaser or its representatives, or any other document or information in any form provided to Purchaser or its representatives in connection with the sale of the Business and the transactions contemplated hereby. Purchaser acknowledges that it has conducted to its satisfaction, its own independent investigation of the Business and, in making the determination to proceed with the transactions contemplated by this Agreement, Purchaser has relied on the results of its own independent investigation.

  • DESCRIPTION OF THE PROPERTY 13.1 The Property as referred to in the Proclamation of Sale shall be deemed to have been correctly and sufficiently described.

  • Description of the Services 1.1 The scope of the service to be rendered is described more fully in the Annexures and Schedules referred to below: ❑ Annexure A – Scope / Specification ❑ Annexure C – Pricing Schedule 2 DELIVERABLES AND COMPLETION DATE The Deliverables, due for completion by and governed by this Schedule 1. In the event that the Service Provider fails to meet the delivery dates as agreed, the following penalties will be imposed:

  • Description of the service 9.1.1 Internet banking service implies an ability for the client to manage and receive remotely the following services from the bank by means of using the special Internet-site of the bank xxxxx://xxx.xxxxxxxxxxxxxxx.xx:

  • Description of the Project THIS SHOULD BE NO MORE THAN A TWO PARAGRAPH DESCRIPTION THAT PROVIDES A BACKGROUND OF THE PROBLEM, AS WELL AS HOW THE CONTRACTOR INTENDS TO SOLVE THE PROBLEM. KEEP IN MIND THAT THE CONTRACT SHOULD “STAND ON ITS OWN,” I.E. ANYONE SHOULD BE ABLE TO PICK IT UP AND FIGURE OUT WHAT IS GOING ON.)

  • The Business The parties acknowledge that the Company is engaged in the development, marketing and sale of certain proprietary technologies, processes and related products in the areas of chemical detection, technical processes, and technical/business services, and that the Company may also from time to time become or may intend to become engaged in other business endeavors (individually and collectively, the "BUSINESS"). The Company shall be deemed to intend to become engaged in a business endeavor if it has devoted or expended any significant resources, either financial or human resources, towards the proposed endeavor, either in planning or implementing the undertaking of such planned endeavor.

  • MANAGEMENT OF THE BUSINESS Pursuant to Section 00-00-000 of the Act, and as stated in its Articles, the Company’s day to day affairs are managed by the Member. The Member is responsible for the daily operations of the business.

  • Operation of the Company’s Business (a) Except in each case (x) as specifically required by any other provision of this Agreement or specifically set forth in Part 5.2(a) of the Disclosure Schedule, (y) as required by any applicable Legal Requirement, or (z) with the prior written consent of Parent, during the Pre-Closing Period: (i) the Company shall conduct its business and operations (A) in the ordinary course and in accordance with past practices and (B) in compliance, in all material respects, with all applicable Legal Requirements and the requirements of all Company Contracts that constitute Material Contracts; (ii) the Company shall use commercially reasonable efforts to preserve intact its current business organization, keep available the services of its current officers and other employees and maintain its relations and goodwill with all suppliers, customers, landlords, creditors, licensors, licensees, distributors, resellers, employees and other Persons having business relationships with the Company; (iii) the Company shall keep in full force all insurance policies referred to in Section 3.19 (other than any such policies that are immediately replaced with substantially similar policies); and (iv) the Company shall promptly notify Parent of (A) any written notice or other communication of which the Company has Knowledge from any Person alleging that the Consent of such Person is or may be required in connection with any of the Contemplated Transactions, and (B) any Legal Proceeding commenced, or, to the Knowledge of the Company, threatened against, relating to, involving or otherwise affecting the Company that relates to the consummation of the Offer or the Merger or any of the other Contemplated Transactions. Except in each case (x) as specifically required by any other provision of this Agreement, (y) as required by any applicable Legal Requirement, or (z) with the prior written consent of the Company, during the Pre-Closing Period, Parent shall promptly notify the Company of (A) any written notice or other communication of which Parent has Knowledge from any Person alleging that the Consent of such Person is or may be required in connection with any of the Contemplated Transactions, and (B) any Legal Proceeding commenced, or, to the Knowledge of Parent, threatened against, relating to, involving or otherwise affecting Parent or Acquisition Sub that relates to the consummation of the Offer or the Merger or any of the other Contemplated Transactions.

  • Description of the Transfer The details of the transfer and of the personal data are specified in Annex B. The parties agree that Annex B may contain confidential business information which they will not disclose to third parties, except as required by law or in response to a competent regulatory or government agency, or as required under clause I(e). The parties may execute additional annexes to cover additional transfers, which will be submitted to the authority where required. Annex B may, in the alternative, be drafted to cover multiple transfers. ANNEX A

Time is Money Join Law Insider Premium to draft better contracts faster.